St. Louis Hills Pharmacy

05/31/2025

https://files.kff.org/attachment/fact-sheet-medicaid-state-MO

Here’s who will be impacted if the state/federal government reduces money allocated to MO Medicaid.

05/27/2025

President Donald Trump signed an executive order on Monday in an effort to make prescription drugs cheaper.That executive order set a 30-day deadline for drugmakers to lower the cost.

05/27/2025

https://aspe.hhs.gov/reports/margins-retail-channel

“According to ERG's estimates, Pharmacy Benefit Managers (PBMs) had the highest profit margins among intermediaries in 2022, at $60.6 billion (31.2 percent). The model suggests that these margins increased from 2020 to 2022 across all drug types.

Brand drugs yield lower margins for pharmacies in dollar value compared to generic drugs (-$0.5 billion for brand drugs, compared with $12.7 billion for generic drugs in 2022).”

Yes that said brand drugs cost pharmacies 500 million of their own money to fill. Not even break even.

05/27/2025

https://www.phrma.org/blog/ftc-finds-pbms-make-billions-in-profit-from-marking-up-cancer-other-critical-generic-drugs

05/07/2025

https://www.ksdk.com/article/news/health/st-louis-measles-exposure-aquarium-confusion-grows/63-ab2f8375-d5f3-4ac0-9822-f29ba4fb9e52?utm_medium=social&utm_source=facebook_KSDK_News

The infected individual's story has been "not the most concrete," investigators said.

05/06/2025

JEFFERSON CITY, MO – The Missouri Department of Health and Senior Services (DHSS) is announcing a confirmed case of measles in an adult resident of New Madrid County. There is no indication of widespread public exposure. Exposure is believed to be limited, and known contacts are being identified and contacted. DHSS is supporting the New Madrid County Health Department in the disease investigation and advising individuals with possible exposure. The case in New Madrid County is not linked to the prior case or prior exposures reported in Missouri.

05/05/2025

Missouri DHSS announces possible measles exposure in St. Louis

JEFFERSON CITY, MO – A confirmed case of measles from an out-of-state resident was reported to have visited the St. Louis Aquarium between 1-6 p.m. on April 30. Additionally, the individual ate at a restaurant in St. Louis on the same day, but available details of this visit have been extremely limited thus far. More details will be provided if they become available.

Because measles is highly contagious, individuals who may have had exposures at the St. Louis Aquarium during the time the person visited and who are unvaccinated or are immunocompromised should consider post-exposure prophylaxis, according to the established public health recommendation to prevent measles infection and its complications. The usual time interval for prophylaxis to be effective is within six days of exposure (by May 6). Those with questions or the need for evaluation should contact their health care provider or local public health agency.

All individuals with possible exposures should watch for the symptoms of measles for 21 days from the date of exposure and report to their local public health agency if symptoms appear. People who think they have measles should isolate themselves and call their health care provider before arriving to be tested. It is important to let the provider know of the concern for measles and to get instructions on how to come to the office for diagnosis without exposing other people to the virus.

01/20/2025

Keep in mind if the new administration imposes tariffs, the price you pay for medications OTC and for cash will increase. Nearly all drug products have chemicals or processing that goes through other countries. The increased costs will get passed on to the purchaser (the pharmacy) which get passed on to the patient (you). If a product isn't impacted by a tariff, the price will probably go up since corporations know they can blame increased prices on tariffs. This is how a global economy and capitalism works.

12/26/2024

https://drugstorenews.com/pbm-rebate-schemes-suppress-biosimilar-humira-cost-patients-6b-iqvia-analysis-finds?utm_source=swiftmail&utm_medium=email&utm_campaign=DSN_NL_Generic&mkt_tok=ODI1LUxTUC01NDUAAAGXnfR-xSG5Yj1dGQQiNWjNuESGo_2AXQ0Uj5BzadN3J_SqzF2QD_hPNLk1V1ZakI71zyPJdCb7-OkUWyCKHknuKV77Nw1Px0fPFiI_cua-swhq&fbclid=IwZXh0bgNhZW0CMTEAAR0FoE9mRe62qirytygZQcSlvDpEfmUAy2Nk2dztbQ-zPabUe3bNFFICeqQ_aem_Wo1Tvr8ZrOY5D1GoyfZtJw

The Biosimilars Council released a new analysis by IQVIA that reveals a PBM strategy to protect $2 billion in profits by “strangling” the biosimilar market and preventing savings for patients.

10/19/2024

https://www.nytimes.com/2024/10/19/business/drugstores-closing-pbm-pharmacy.html?unlocked_article_code=1.TU4.INCu.-jRQQeOMrUI0&smid=url-share

The biggest pharmacy benefit managers are profiting by systematically underpaying independent drugstores, creating “pharmacy deserts” across the country.

09/18/2024

https://thehill.com/policy/healthcare/4884456-express-scripts-ftc-lawsuit/

Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and demanded the agency retract a report saying the industry middlemen contr…

09/13/2024

New flu and covid shots are now in. Stop in to get the most up to date protection.